ArticleBMC pediatrics2025

Treatment of thrombotic microangiopathy associated with systemic lupus erythematosus with low-dose rituximab as an induction agent and belimumab as a maintenance agent.

Zhenle Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.